Description

Not another GLP-1. Something more advanced.

RESET contains Retatrutide — a next-generation multi-receptor peptide that works on GLP-1, GIP, and glucagon pathways simultaneously. That triple-receptor action is what separates it from single-pathway compounds in early clinical research, with studies showing substantial reductions in body weight.

Ongoing research suggests RESET may support:

• Significant weight loss through multiple metabolic pathways
• Appetite suppression and increased satiety via GLP-1 and GIP receptors
• Improved insulin sensitivity and better blood sugar control
• Increased calorie burning through glucagon receptor activity
• Improved lipid (cholesterol) profiles

Lab-tested 98%+ purity. cGMP manufactured. For research use only.